AP
MED icon

AHL Partners’s Medifast MED Stock Holding History

AHL Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$600K Buy
+8,597
New +$570K 0.01% 1040
2017
Q3 		– Sell
-5,800
Closed -$241K – 1269
2017
Q2 		$241K Buy
+5,800
New +$252K 0.01% 1062

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AHL Partners's MED Position: Q4 2017 in Review

AHL Partners opened a new position in Medifast (MED) in Q4 2017: 8,597 shares worth $600K. The stake represents 0.01% of the portfolio and ranks #1040 among its holdings. This is a return to the name: AHL Partners previously reported a position in MED as recently as Q2 2017.

AHL Partners first reported a position in MED in Q2 2017 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold MED as of Q4 2017.

  • AHL Partners held 8,597 shares of Medifast worth $600K as of Q4 2017.
  • Medifast was a new AHL Partners position in Q4 2017.
  • Medifast made up 0.01% of AHL Partners's portfolio in Q4 2017, its #1040 holding.
  • AHL Partners first reported a position in Medifast in Q2 2017 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Medifast as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.